Overexpression of Numb suppresses tumor cell growth and enhances sensitivity to cisplatin in epithelioid malignant pleural mesothelioma

Kang,Yanmeng; Ding,Mingjie; Tian,Guangyan; Guo,Haisheng; Wan,Yunyan; Yao,Zhouhong; Li,Bin; Lin,Dianjie

doi:10.3892/or.2013.2429

Overexpression of Numb suppresses tumor cell growth and enhances sensitivity to cisplatin in epithelioid malignant pleural mesothelioma

Authors:
- Yanmeng Kang
- Mingjie Ding
- Guangyan Tian
- Haisheng Guo
- Yunyan Wan
- Zhouhong Yao
- Bin Li
- Dianjie Lin
View Affiliations

Affiliations: Department of Respiratory Medicine, Shandong Provincial Hospital, Shandong University, Jinan, Shandong 250021, P.R. China, Department of Respiratory Medicine, Jinan Children's Hospital, Jinan, Shandong 250022, P.R. China, Department of Neurology, Jinan Children's Hospital, Jinan, Shandong 250022, P.R. China, Department of Oncology, Dongying People's Hospital, Dongying 257091, P.R. China
Published online on: April 26, 2013 https://doi.org/10.3892/or.2013.2429
Pages: 313-319

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Malignant pleural mesothelioma (MPM) is a highly aggressive and conventional treatment-resistant tumor with a dismal prognosis. Among the three histological subtypes of MPM, the epithelioid is the most common type. Numb is considered as a tumor suppressor playing a critical role in controlling asymmetric cell division, maintenance of stem cell compartments, ubiquitination of specific substrates and regulating Notch-, Hedgehog- and TP53-activated pathways. The present study was designed to analyze the role of Numb in epithelioid MPM. We investigated the expression of Numb in 39 epithelioid MPM and 22 normal pleural tissues by immunohistochemistry. Furthermore, we overexpressed Numb in NCI-H2452, an epithelioid human MPM cell line, and investigated the effect of Numb overexpression on the proliferation, apoptosis and sensitivity to cisplatin in cells. The expression of Numb was significantly lower in MPM compared to the control group and Numb had an inverse correlation with the ki-67 labeling index. Loss of Numb expression was associated with poor prognosis in epithelioid MPM. Overexpression of Numb in NCI-H2452 cells significantly inhibited proliferation, promoted apoptosis and enhanced sensitivity to cisplatin. Moreover, Numb overexpression activated caspase-9 and caspase-3 through release of cytochrome c as well as downregulation of XIAP and survivin. We speculate that cytochrome c/caspase signaling is a possible mechanism through which Numb enhances the apoptosis of NCI-H2452 cells. These results suggest that Numb may be involved in epithelioid MPM development, and its upregulation may confer sensitivity to cisplatin, suggesting potential therapeutic options for MPM.

View Figures

View References

1	Peto J, Decarli A, La Vecchia C, Levi F and Negri E: The European mesothelioma epidemic. Br J Cancer. 79:666–672. 1999. View Article : Google Scholar : PubMed/NCBI
2	Bianchi C and Bianchi T: Malignant mesothelioma: global incidence and relationship with asbestos. Ind Health. 45:379–387. 2007. View Article : Google Scholar : PubMed/NCBI
3	Robinson BWS, Musk AW and Lake RA: Malignant mesothelioma. Lancet. 366:397–408. 2005. View Article : Google Scholar
4	Beachy PA, Karhadkar SS and Berman DM: Tissue repair and stem cell renewal in carcinogenesis. Nature. 432:324–331. 2004. View Article : Google Scholar : PubMed/NCBI
5	Uemura T, Shepherd S, Ackerman L, Jan LY and Jan YN: numb, a gene required in determination of cell fate during sensory organ formation in Drosophila embryos. Cell. 58:349–360. 1989. View Article : Google Scholar
6	Rhyu MS, Jan LY and Jan YN: Asymmetric distribution of numb protein during division of the sensory organ precursor cell confers distinct fates to daughter cells. Cell. 76:477–491. 1994. View Article : Google Scholar : PubMed/NCBI
7	Morrison SJ and Spradling AC: Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell. 132:598–611. 2008. View Article : Google Scholar : PubMed/NCBI
8	Rašin MR, Gazula VR, Breunig JJ, et al: Numb and Numbl are required for maintenance of cadherin-based adhesion and polarity of neural progenitors. Nat Neurosci. 10:819–827. 2007.PubMed/NCBI
9	Nishimura T and Kaibuchi K: Numb controls integrin endocytosis for directional cell migration with aPKC and PAR-3. Dev Cell. 13:15–28. 2007. View Article : Google Scholar : PubMed/NCBI
10	McGill MA and McGlade CJ: Mammalian numb proteins promote Notch1 receptor ubiquitination and degradation of the Notch1 intracellular domain. J Biol Chem. 278:23196–23203. 2003. View Article : Google Scholar : PubMed/NCBI
11	Di Marcotullio L, Ferretti E, Greco A, et al: Numb is a suppressor of Hedgehog signalling and targets Gli1 for Itch-dependent ubiquitination. Nat Cell Biol. 8:1415–1423. 2006.PubMed/NCBI
12	Colaluca IN, Tosoni D, Nuciforo P, et al: NUMB controls p53 tumour suppressor activity. Nature. 451:76–80. 2008. View Article : Google Scholar : PubMed/NCBI
13	Pece S, Confalonieri S, Romano PR and Di Fiore PP: NUMB-ing down cancer by more than just a NOTCH. Biochim Biophys Acta. 1815:26–43. 2011.PubMed/NCBI
14	Singh A and Settleman J: EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene. 29:4741–4751. 2010. View Article : Google Scholar : PubMed/NCBI
15	Thiery JP, Acloque H, Huang RYJ and Nieto MA: Epithelial-mesenchymal transitions in development and disease. Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
16	Lanzetti L and Di Fiore PP: Endocytosis and cancer: an ‘insider’ network with dangerous liaisons. Traffic. 9:2011–2021. 2008.
17	Vaccari T and Bilder D: At the crossroads of polarity, proliferation and apoptosis: the use of Drosophila to unravel the multifaceted role of endocytosis in tumor suppression. Mol Oncol. 3:354–365. 2009. View Article : Google Scholar : PubMed/NCBI
18	Goldstein B and Macara IG: The PAR proteins: fundamental players in animal cell polarization. Dev Cell. 13:609–622. 2007. View Article : Google Scholar : PubMed/NCBI
19	Aranda V, Nolan ME and Muthuswamy SK: Par complex in cancer: a regulator of normal cell polarity joins the dark side. Oncogene. 27:6878–6887. 2008. View Article : Google Scholar : PubMed/NCBI
20	Pece S, Serresi M, Santolini E, et al: Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis. J Cell Biol. 167:215–221. 2004. View Article : Google Scholar : PubMed/NCBI
21	Westhoff B, Colaluca IN, D’Ario G, et al: Alterations of the Notch pathway in lung cancer. Proc Natl Acad Sci USA. 106:22293–22298. 2009. View Article : Google Scholar : PubMed/NCBI
22	Caussinus E and Gonzalez C: Induction of tumor growth by altered stem-cell asymmetric division in Drosophila melanogaster. Nat Genet. 37:1125–1129. 2005. View Article : Google Scholar : PubMed/NCBI
23	Bric A, Miething C, Bialucha CU, et al: Functional identification of tumor-suppressor genes through an in vivo RNA interference screen in a mouse lymphoma model. Cancer Cell. 16:324–335. 2009. View Article : Google Scholar : PubMed/NCBI
24	Maiorano E, Favia G, Pece S, et al: Prognostic implications of NUMB immunoreactivity in salivary gland carcinomas. Int J Immunopathol Pharmacol. 20:779–789. 2007.PubMed/NCBI
25	Marino S: Medulloblastoma: developmental mechanisms out of control. Trends Mol Med. 11:17–22. 2005. View Article : Google Scholar : PubMed/NCBI
26	Yan B, Omar FM, Das K, et al: Characterization of Numb expression in astrocytomas. Neuropathology. 28:479–484. 2008. View Article : Google Scholar : PubMed/NCBI
27	Travis W, Brambilla E, Muller-Hermelink H and Harris C; World Health Organization Classification of Tumours. Pathology & Genetics. Tumours of the Lung, Pleura, Thymus and Heart. IARC Press; Lyon: 2004
28	Heidebrecht H, Buck F, Endl E, Kruse M, Adam K and Andresen K: Ki-67-Mcm6, a new MoAb specific to Mcm6: comparison of the distribution profile of Mcm6 and Ki-67 antigen. Lab Invest. 81:1163–1165. 2008. View Article : Google Scholar : PubMed/NCBI
29	Adams JM and Cory S: The Bcl-2 protein family: arbiters of cell survival. Science. 281:1322–1326. 1998. View Article : Google Scholar : PubMed/NCBI
30	Kleinberg L, Lie AK, Flørenes VA, Nesland JM and Davidson B: Expression of inhibitor-of-apoptosis protein family members in malignant mesothelioma. Hum Pathol. 38:986–994. 2007. View Article : Google Scholar : PubMed/NCBI
31	Wu M, Yuan S, Szporn AH, Gan L, Shtilbans V and Burstein DE: Immunocytochemical detection of XIAP in body cavity effusions and washes. Mod Pathol. 18:1618–1622. 2005.PubMed/NCBI
32	Gordon G, Mani M, Mukhopadhyay L, et al: Expression patterns of inhibitor of apoptosis proteins in malignant pleural mesothelioma. J Pathol. 211:447–454. 2007. View Article : Google Scholar : PubMed/NCBI
33	Gordon G, Mani M, Mukhopadhyay L, et al: Inhibitor of apoptosis proteins are regulated by tumour necrosis factor-α in malignant pleural mesothelioma. J Pathol. 211:439–446. 2007.
34	Hmeljak J, Erčulj N, Dolžan V, Kern I and Cör A: BIRC5 promoter SNPs do not affect nuclear survivin expression and survival of malignant pleural mesothelioma patients. J Cancer Res Clin Oncol. 137:1641–1651. 2011. View Article : Google Scholar : PubMed/NCBI
35	Tamm I, Wang Y, Sausville E, et al: IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res. 58:5315–5320. 1998.PubMed/NCBI
36	Kobayashi K, Hatano M, Otaki M, Ogasawara T and Tokuhisa T: Expression of a murine homologue of the inhibitor of apoptosis protein is related to cell proliferation. Proc Natl Acad Sci USA. 96:1457–1462. 1999. View Article : Google Scholar : PubMed/NCBI
37	Kim KW, Mutter RW, Willey CD, et al: Inhibition of survivin and aurora B kinase sensitizes mesothelioma cells by enhancing mitotic arrests. Int J Radiat Oncol Biol Phys. 67:1519–1525. 2007. View Article : Google Scholar : PubMed/NCBI
38	Xia C, Xu Z, Yuan X, et al: Induction of apoptosis in mesothelioma cells by antisurvivin oligonucleotides. Mol Cancer Ther. 1:687–694. 2002.PubMed/NCBI
39	Rabik CA and Dolan ME: Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev. 33:9–23. 2007. View Article : Google Scholar : PubMed/NCBI
40	Boulikas T and Vougiouka M: Cisplatin and platinum drugs at the molecular level (Review). Oncol Rep. 10:663–682. 2003.PubMed/NCBI
41	Ikuta K, Takemura K, Kihara M, et al: Defects in apoptotic signal transduction in cisplatin-resistant non-small cell lung cancer cells. Oncol Rep. 13:1229–1234. 2005.PubMed/NCBI
42	Okouoyo S, Herzer K, Ucur E, et al: Rescue of death receptor and mitochondrial apoptosis signaling in resistant human NSCLC in vivo. Int J Cancer. 108:580–587. 2003. View Article : Google Scholar : PubMed/NCBI
43	Yang X, Zheng F, Xing H, et al: Resistance to chemotherapy-induced apoptosis via decreased caspase-3 activity and overexpression of antiapoptotic proteins in ovarian cancer. J Cancer Res Clin Oncol. 130:423–428. 2004. View Article : Google Scholar : PubMed/NCBI
44	Mueller T, Voigt W, Simon H, et al: Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer. Cancer Res. 63:513–521. 2003.PubMed/NCBI